دورية أكاديمية
أعرض في EDS

Effect of four different forms of high intensity training on BDNF response to Wingate and Graded Exercise Test.

التفاصيل البيبلوغرافية
العنوان: Effect of four different forms of high intensity training on BDNF response to Wingate and Graded Exercise Test.
المؤلفون: Murawska-Ciałowicz E; Physiology and Biochemistry Department, University School of Physical Education, Wrocław, Poland. eugenia.murawska-cialowicz@awf.wroc.pl., de Assis GG; Department of Molecular Biology, Gdansk University of Physical Education and Sport, Gdańsk, Poland.; Mossakowski Medical Research Centre, PAN, Warsaw, Poland., Clemente FM; Escola Superior Desporto E Lazer, Instituto Politécnico de Viana Do Castelo, Viana do Castelo, Portugal.; Instituto de Telecomunicações, Delegação da Covilhã, Covilhã, Portugal., Feito Y; Department of Exercise Science and Sport Management, Kennesaw State University, Kennesaw, USA., Stastny P; Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic., Zuwała-Jagiełło J; Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Wrocław, Poland., Bibrowicz B; Polish Strength & Conditioning Association, Wrocław, Poland., Wolański P; Physiology and Biochemistry Department, University School of Physical Education, Wrocław, Poland.
المصدر: Scientific reports [Sci Rep] 2021 Apr 21; Vol. 11 (1), pp. 8599. Date of Electronic Publication: 2021 Apr 21.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Brain-Derived Neurotrophic Factor/*metabolism , Exercise/*physiology, Adult ; Body Mass Index ; Exercise Test/methods ; High-Intensity Interval Training/methods ; Humans ; Male ; Rest/physiology
مستخلص: This study examined the effects of a nine-week intervention of four different high-intensity training modalities [high-intensity functional training (HIFT), high-intensity interval training (HIIT), high-intensity power training (HIPT), and high-intensity endurance training (HIET)] on the resting concentration of brain-derived neurotropic factor (BDNF). In addition, we evaluated the BDNF responses to Graded Exercise Test (GXT) and Wingate Anaerobic Test (WAnT) in men. Thirty-five healthy individuals with body mass index 25.55 ± 2.35 kg/m 2 voluntarily participated in this study and were randomly assigned into four training groups. During nine-weeks they completed three exercise sessions per week for one-hour. BDNF was analyzed before and after a GXT and WAnT in two stages: (stage 0-before training and stage 9-after nine weeks of training). At stage 0, an increase in BDNF concentration was observed in HIFT (33%; p < 0.05), HIPT (36%; p < 0.05) and HIIT (38%; p < 0.05) after GXT. Even though HIET showed an increase in BDNF (10%) this was not statistically significant (p > 0.05). At stage 9, higher BDNF levels after GXT were seen only for the HIFT (30%; p < 0.05) and HIIT (18%; p < 0.05) groups. Reduction in BDNF levels were noted after the WAnT in stage 0 for HIFT (- 47%; p < 0.01), HIPT (- 49%; p < 0.001), HIET (- 18%; p < 0.05)], with no changes in the HIIT group (- 2%). At stage 9, BDNF was also reduced after WAnT, although these changes were lower compared to stage 0. The reduced level of BDNF was noted in the HIFT (- 28%; p < 0.05), and HIPT (- 19%;p < 0.05) groups. Additionally, all groups saw an improvement in VO 2max (8%; p < 0.001), while BDNF was also correlated with lactate and minute ventilation and selected WAnT parameters. Our research has shown that resting values of BDNF after nine weeks of different forms of high-intensity training (HIT) have not changed or were reduced. Resting BDNF measured at 3th (before GXT at stage 9) and 6th day after long lasting HITs (before WAnT at stage 9) did not differed (before GXT), but in comparison to the resting value before WAnT at the baseline state, was lower in three groups. It appears that BDNF levels after one bout of exercise is depended on duration time, intensity and type of test/exercise.
References: Nature. 2012 Jan 11;481(7382):463-8. (PMID: 22237023)
Curr Pharm Des. 2012;18(36):5920-35. (PMID: 22681170)
J Biol Rhythms. 2017 Feb;32(1):75-82. (PMID: 28326910)
Eur J Appl Physiol. 2010 Sep;110(2):285-93. (PMID: 20467874)
Gen Physiol Biophys. 2009;28 Spec No:179-83. (PMID: 19893098)
NPJ Aging Mech Dis. 2015 Oct 29;1:15009. (PMID: 28721258)
Eur J Sport Sci. 2020 May;20(4):516-524. (PMID: 31386821)
Front Neurol. 2019 Jun 04;10:515. (PMID: 31231295)
Hippocampus. 2009 Oct;19(10):973-80. (PMID: 19437410)
J Endocrinol. 2008 May;197(2):429-35. (PMID: 18434373)
Neuropsychopharmacology. 2016 Dec;41(13):3070-3079. (PMID: 27388329)
J Neuroimmune Pharmacol. 2013 Sep;8(4):824-39. (PMID: 23821340)
J Clin Med. 2020 Apr 15;9(4):. (PMID: 32326586)
J Sports Sci Med. 2012 Mar 01;11(1):83-8. (PMID: 24137066)
Nat Rev Neurosci. 2009 Dec;10(12):850-60. (PMID: 19927149)
J Physiol Pharmacol. 2015 Dec;66(6):811-21. (PMID: 26769830)
Neuroreport. 2012 Oct 24;23(15):889-93. (PMID: 22964969)
PLoS One. 2012;7(11):e48046. (PMID: 23133609)
Hippocampus. 2005;15(2):246-53. (PMID: 15476265)
J Neurosci. 1990 Nov;10(11):3469-78. (PMID: 2230938)
J Physiol. 2010 Mar 15;588(Pt 6):1011-22. (PMID: 20100740)
Eur Rev Aging Phys Act. 2020 Jan 06;17:2. (PMID: 31921371)
Bratisl Lek Listy. 2014;115(10):607-10. (PMID: 25573725)
Sports Med. 2002;32(1):53-73. (PMID: 11772161)
J Biol Chem. 2016 May 6;291(19):9872-81. (PMID: 27006395)
Nat Neurosci. 2007 Sep;10(9):1089-93. (PMID: 17726474)
Clinics (Sao Paulo). 2010;65(11):1123-6. (PMID: 21243284)
Front Neuroendocrinol. 2019 Oct;55:100784. (PMID: 31425696)
J Comp Neurol. 2005 May 23;486(1):39-47. (PMID: 15834963)
Front Neurosci. 2011 Apr 12;5:51. (PMID: 21559064)
J Gerontol A Biol Sci Med Sci. 2000 Jul;55(7):B336-46. (PMID: 10898247)
Neurosci Lett. 2008 May 23;437(1):29-32. (PMID: 18420345)
Riv Psichiatr. 2009 Mar-Apr;44(2):79-87. (PMID: 20066808)
Eur J Appl Physiol. 2022 Feb;122(2):531-539. (PMID: 34853894)
J Frailty Aging. 2017;6(1):53-58. (PMID: 28244559)
J Cereb Blood Flow Metab. 2009 Jun;29(6):1121-9. (PMID: 19337275)
Medicine (Baltimore). 2016 Oct;95(43):e5260. (PMID: 27787389)
Front Cell Neurosci. 2019 Aug 07;13:363. (PMID: 31440144)
J Physiol. 2009 Dec 1;587(Pt 23):5559-68. (PMID: 19752112)
Physiol Rep. 2019 Jun;7(11):e14140. (PMID: 31175708)
Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1303-10. (PMID: 21451146)
Neural Plast. 2017;2017:7260130. (PMID: 28928987)
Eur J Appl Physiol. 2014 Sep;114(9):1853-62. (PMID: 24880226)
Biomed Res Int. 2015;2015:165078. (PMID: 26557653)
Front Neurosci. 2018 Nov 14;12:839. (PMID: 30487731)
Psychoneuroendocrinology. 2011 Feb;36(2):228-39. (PMID: 20702043)
Am J Physiol Regul Integr Comp Physiol. 2011 May;300(5):R1053-69. (PMID: 21346243)
Exerc Sport Sci Rev. 2008 Apr;36(2):58-63. (PMID: 18362686)
Biol Sport. 2016 Mar;33(1):7-13. (PMID: 26985128)
J Appl Physiol (1985). 2015 Dec 15;119(12):1363-73. (PMID: 26472862)
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8738-43. (PMID: 23650363)
Physiol Rev. 2008 Oct;88(4):1379-406. (PMID: 18923185)
Clin Physiol Funct Imaging. 2013 Jan;33(1):30-7. (PMID: 23216763)
Exp Neurol. 1995 Feb;131(2):229-38. (PMID: 7534721)
Trends Endocrinol Metab. 2009 Apr;20(3):95-9. (PMID: 19269849)
Front Biosci (Landmark Ed). 2018 Jan 1;23(4):726-751. (PMID: 28930569)
Neuropharmacology. 1998 Dec;37(12):1553-61. (PMID: 9886678)
Sci Signal. 2019 Aug 13;12(594):. (PMID: 31409756)
Dose Response. 2020 Dec 10;18(4):1559325820970818. (PMID: 33354170)
PLoS One. 2014 Jan 14;9(1):e85276. (PMID: 24454832)
PLoS One. 2018 Nov 6;13(11):e0205791. (PMID: 30399190)
Int J Mol Sci. 2018 Nov 19;19(11):. (PMID: 30463271)
Int J Environ Res Public Health. 2020 May 20;17(10):. (PMID: 32443802)
Sports Med. 2013 May;43(5):313-38. (PMID: 23539308)
J Biosci. 2006 Sep;31(3):423-34. (PMID: 17006024)
Biology (Basel). 2016 Oct 08;5(4):. (PMID: 27740597)
Brain Res. 2006 Nov 22;1121(1):59-65. (PMID: 17010953)
Int J Med Sci. 2020 Oct 18;17(18):3058-3064. (PMID: 33173426)
FEBS Lett. 2000 Mar 24;470(2):113-7. (PMID: 10734218)
Cell Metab. 2013 Nov 5;18(5):649-59. (PMID: 24120943)
Mol Biol Cell. 2010 Jul 1;21(13):2182-90. (PMID: 20427568)
Exp Physiol. 2009 Oct;94(10):1062-9. (PMID: 19666694)
Horm Metab Res. 2010 Dec;42(13):982-6. (PMID: 21053157)
Trends Neurosci. 2009 May;32(5):283-90. (PMID: 19349082)
Neurosci Lett. 2010 Jul 26;479(2):161-5. (PMID: 20553806)
Trends Neurosci. 2002 Jun;25(6):295-301. (PMID: 12086747)
J Physiol. 2012 Mar 1;590(5):1077-84. (PMID: 22289907)
Int J Endocrinol. 2018 Oct 9;2018:7816806. (PMID: 30402097)
J Exp Med. 1999 Mar 1;189(5):865-70. (PMID: 10049950)
J Sports Sci Med. 2019 Jun 01;18(2):359-368. (PMID: 31191107)
Curr Neuropharmacol. 2016;14(7):721-31. (PMID: 26786147)
Sports Med. 2007;37(12):1019-28. (PMID: 18027991)
Genes (Basel). 2019 Sep 17;10(9):. (PMID: 31533339)
Scand J Med Sci Sports. 2016 Aug;26(8):885-93. (PMID: 26247789)
J Obes. 2019 Nov 3;2019:4537274. (PMID: 31781387)
Endocrinology. 2010 Jan;151(1):253-61. (PMID: 19880806)
Appl Physiol Nutr Metab. 2019 May;44(5):499-506. (PMID: 30286300)
Neuron. 1997 Nov;19(5):1031-47. (PMID: 9390517)
J Sports Sci Med. 2013 Sep 01;12(3):502-11. (PMID: 24149158)
Neural Regen Res. 2016 Sep;11(9):1471-1479. (PMID: 27857753)
Psychoneuroendocrinology. 2012 Jun;37(6):844-51. (PMID: 22029953)
J Sports Sci Med. 2017 Jun 01;16(2):219-229. (PMID: 28630575)
Handb Exp Pharmacol. 2014;220:223-50. (PMID: 24668475)
Sci Rep. 2019 Jul 4;9(1):9655. (PMID: 31273250)
J Strength Cond Res. 2001 Feb;15(1):109-15. (PMID: 11708692)
Med Sci Sports Exerc. 2016 Jul;48(7):1347-54. (PMID: 26909534)
Pflugers Arch. 2017 Jun;469(5-6):593-610. (PMID: 28280960)
J Diabetes Res. 2017;2017:1039161. (PMID: 28386566)
Endocr Rev. 2020 Aug 1;41(4):. (PMID: 32393961)
Exp Physiol. 2009 Dec;94(12):1153-60. (PMID: 19748969)
Sports (Basel). 2018 Aug 07;6(3):. (PMID: 30087252)
Med Sci Sports Exerc. 2007 Apr;39(4):728-34. (PMID: 17414812)
Neurobiol Aging. 2005 Jan;26(1):115-23. (PMID: 15585351)
Sports (Basel). 2019 Sep 02;7(9):. (PMID: 31480686)
Diabetologia. 2009 Jul;52(7):1409-18. (PMID: 19387610)
J Neurosci. 2019 Mar 27;39(13):2369-2382. (PMID: 30692222)
المشرفين على المادة: 0 (Brain-Derived Neurotrophic Factor)
7171WSG8A2 (BDNF protein, human)
تواريخ الأحداث: Date Created: 20210422 Date Completed: 20211110 Latest Revision: 20231101
رمز التحديث: 20231101
مُعرف محوري في PubMed: PMC8060323
DOI: 10.1038/s41598-021-88069-y
PMID: 33883635
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-021-88069-y